Key facts
- Notable investors include Tech Incubator Program for Startup, Klim Ventures.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Evom AI
- ·The full record, as it builds
Funding rounds
No funding rounds for Evom AI are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Evom AI
Developer of an autonomous artificial intelligence system, designed for real-time cardiovascular diagnostics and care. The company platform utilises artificial intelligence to deliver insights by automating electrocardiography measurements, instantly flagging critical electrocardiogram abnormalities, and unifying multimodal data for holistic decision support, enabling clinicians and patients to achieve faster, smarter, and more reliable proactive and preventive cardiovascular care.
- Sector
- Healthcare
- HQ
- Seoul, South Korea
- Founded
- 2025
- Employees
- 5
- Website
- evom.ai/
- Ownership
- Privately Held (backing)
Evom AI doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Evom AI shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Evom AI in its N-PORT filings yet. We sweep new filings monthly.